{"id":84,"date":"2019-11-28T11:24:01","date_gmt":"2019-11-28T11:24:01","guid":{"rendered":"https:\/\/more.bham.ac.uk\/chiltern\/?page_id=84"},"modified":"2020-02-11T12:33:04","modified_gmt":"2020-02-11T12:33:04","slug":"deliverables","status":"publish","type":"page","link":"https:\/\/more.bham.ac.uk\/chiltern\/deliverables\/","title":{"rendered":"Deliverables"},"content":{"rendered":"\n<div class=\"alignwide wp-block-ugb-container ugb-container ugb-c958a40 ugb-container--v2 ugb-container--design-basic ugb-container--width-small ugb-main-block\" id=\"\"><div class=\"ugb-inner-block\"><div class=\"ugb-block-content\"><div class=\"ugb-container__wrapper ugb-c958a40-wrapper\"><div class=\"ugb-container__side\"><div class=\"ugb-container__content-wrapper ugb-c958a40-content-wrapper\">\n<p>ChiLTERN deliverables are tangible items such as a report or website that have to be documented by the lead and uploaded via the&nbsp;<a href=\"http:\/\/ec.europa.eu\/research\/participants\/portal\/desktop\/en\/home.html\">Participant Portal<\/a>&nbsp;to the European Commission by the contracted deadline ().&nbsp; <\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Deliverables<\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>D1.1 Project Management Manual (6) UoB &#8211; submitted and approved<\/li><li>D1.2 Data Management Plan (6) UoB&nbsp;&#8211; submitted and approved<\/li><li>D2.1&nbsp;Registration in ISRCTN (12) UoB&nbsp;&#8211; submitted and approved<\/li><li>D2.2&nbsp;Protocol finalisation and submission to EC (12) UoB&nbsp;&#8211; submitted and approved<\/li><li>D2.3&nbsp;Ethics &amp; regulatory approval in UK and submission to EC (12) UoB&nbsp;&#8211; submitted and approved<\/li><li>D2.4 Ethics &amp; regulatory approval in 50% of NCC countries (18) UoB &#8211; submitted&nbsp;<\/li><li>D2.5&nbsp;Trial Progress report (18) UoB &#8211; submitted and approved<\/li><li>D2.6&nbsp;Mid-recruitment report (36) UoB &#8211; submitted<\/li><li>D2.7&nbsp;Trial Progress report 3 (54) UoB<\/li><li>D2.8&nbsp;Trial publication report (60) UoB<\/li><li>D2.9&nbsp;Submission of approvals package to EC (60) UoB<\/li><li>D3.1&nbsp;Report on biobanking activities (36) IGTP &#8211; submitted<\/li><li>D3.2&nbsp;Website optimization to register sample collection (18) CINECA&nbsp;&#8211; submitted and approved<\/li><li>D3.3 Report on pathological review activities (36) UNIPD &#8211; submitted<\/li><li>D3.4&nbsp;Report on the optimised panel of biomarkers (54) IGTP<\/li><li>D3.5&nbsp;Report on validated biomarkers in diagnostic specimens (54) IGTP<\/li><li>D3.6 Report on new biomarkers identified in aggressive childhood cancers (54) LMU<\/li><li>D3.7&nbsp;Report on similarities and differences between paediatric and adult HCC (54) UKB<\/li><li>D4.1&nbsp;Report on the first step to a validation of the new clinical risk stratification CHIC HS (36) LMU<\/li><li>D4.2&nbsp;Report of the validation of CHIC HS within the first part of the PHITT trial data (60) LMU<\/li><li>D4.3&nbsp;Report of the inclusion of pathology and biology marker into a new clinical-pathological-biological version of the classification (60) LMU<\/li><li>D5.1Web-based surgical review platform (18) EKUT&nbsp;&#8211; submitted and approved<\/li><li>D5.2&nbsp;Report on imaging data collection activities (36) EKUT<\/li><li>D5.3&nbsp;Report on surgical review activities (36) EKUT<\/li><li>D5.4&nbsp;Report on surgical review activitiesReport on the outcome of patients with PRETEXT III\/IV HB undergoing surgery (54) EKUT<\/li><li>D5.5&nbsp;Report on validated factors for surgical decision making (54) EKUT<\/li><li>D5.6&nbsp;Report on factors identifying patients for computer assisted surgery planning (54) EKUT<\/li><li>D5.7&nbsp;Report of clinical recommendations for children with PRETEXT III\/IV Hepatoblastoma: extended resection or primary liver transplantation (60) EKUT<\/li><li>D6.1&nbsp;Protocols for standardised collection of clinical samples and sample analysis (18) UNEW&nbsp;&#8211; submitted and approved<\/li><li>D6.2&nbsp;Collection of samples and pharmacokinetic analysis (18) UNEW &#8211; submitted<\/li><li>D6.3&nbsp;Collection of samples and biomarker analysis (18) UNEW<\/li><li>D6.4&nbsp;Analysis of pharmacogenetic data (54) UNEW<\/li><li>D6.5&nbsp;Final WP6 report (60) UNEW<\/li><li>D7.1&nbsp;Dissemination and Communication Plan: and updated regularly (18) UoB&nbsp;&#8211; submitted and approved<\/li><li>D7.2&nbsp;Publication Policy (18) UoB &#8211; submitted and approved<\/li><li>D7.3&nbsp;Website activation (18) UoB&nbsp;&#8211; submitted and approved<\/li><\/ul>\n<\/div><\/div><\/div><\/div><\/div><\/div>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ChiLTERN deliverables are tangible items such as a report or website that have to be documented by the lead and uploaded via the&nbsp;Participant Portal&nbsp;to the European Commission by the contracted deadline ().&nbsp; Deliverables D1.1 Project Management Manual (6) UoB &#8211; submitted and approved D1.2 Data Management Plan (6) UoB&nbsp;&#8211; submitted and approved D2.1&nbsp;Registration in ISRCTN [&hellip;]<\/p>\n","protected":false},"author":105,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-84","page","type-page","status-publish","hentry"],"featured_image_urls_v2":{"full":"","thumbnail":"","medium":"","medium_large":"","large":"","1536x1536":"","2048x2048":"","ab-block-post-grid-landscape":"","ab-block-post-grid-square":"","post-thumbnail":"","twentytwenty-fullscreen":""},"post_excerpt_stackable_v2":"<p>ChiLTERN deliverables are tangible items such as a report or website that have to be documented by the lead and uploaded via the&nbsp;Participant Portal&nbsp;to the European Commission by the contracted deadline ().&nbsp; Deliverables D1.1 Project Management Manual (6) UoB &#8211; submitted and approvedD1.2 Data Management Plan (6) UoB&nbsp;&#8211; submitted and approvedD2.1&nbsp;Registration in ISRCTN (12) UoB&nbsp;&#8211; submitted and approvedD2.2&nbsp;Protocol finalisation and submission to EC (12) UoB&nbsp;&#8211; submitted and approvedD2.3&nbsp;Ethics &amp; regulatory approval in UK and submission to EC (12) UoB&nbsp;&#8211; submitted and approvedD2.4 Ethics &amp; regulatory approval in 50% of NCC countries (18) UoB &#8211; submitted&nbsp;D2.5&nbsp;Trial Progress report (18) UoB &#8211;&hellip;<\/p>\n","category_list_v2":"","author_info_v2":{"name":"cartersc","url":"https:\/\/more.bham.ac.uk\/chiltern\/author\/cartersc\/"},"comments_num_v2":"0 comments","featured_image_src":null,"featured_image_src_square":null,"_links":{"self":[{"href":"https:\/\/more.bham.ac.uk\/chiltern\/wp-json\/wp\/v2\/pages\/84","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/more.bham.ac.uk\/chiltern\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/more.bham.ac.uk\/chiltern\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/more.bham.ac.uk\/chiltern\/wp-json\/wp\/v2\/users\/105"}],"replies":[{"embeddable":true,"href":"https:\/\/more.bham.ac.uk\/chiltern\/wp-json\/wp\/v2\/comments?post=84"}],"version-history":[{"count":7,"href":"https:\/\/more.bham.ac.uk\/chiltern\/wp-json\/wp\/v2\/pages\/84\/revisions"}],"predecessor-version":[{"id":633,"href":"https:\/\/more.bham.ac.uk\/chiltern\/wp-json\/wp\/v2\/pages\/84\/revisions\/633"}],"wp:attachment":[{"href":"https:\/\/more.bham.ac.uk\/chiltern\/wp-json\/wp\/v2\/media?parent=84"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}